Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus.

The British journal of nutrition

Volumn 111, Issue 5, 2014, Pages 836-846

  Zhao, Haifeng ^a   Li, Xuemin ^a   Li, N ^a   Liu, Tiantian ^a   Liu, Juan ^a   Li, Ziwei ^a   Xiao, Huihui ^a   Li, Jinhui ^a  

^a SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHYTOESTROGEN; RESVERATROL; STILBENE DERIVATIVE; TNFRSF11B PROTEIN, RAT;

ANIMAL; ARTICLE; BLOOD; BONE DENSITY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIET SUPPLEMENTATION; DISEASE MODEL; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; FEMUR; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZATION; RAT; TIME; URINE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PHYTOESTROGENS; RANDOM ALLOCATION; RANK LIGAND; RATS; RATS, WISTAR; STILBENES; TIME FACTORS;

EID: 84899748475     PISSN: None     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003115     Document Type: Article

References (0)